Home » Intellectual Property

Intellectual Property and Trade

IP: Imperative for Innovation

Patent systems can provide an advantage to society by rewarding the development of new inventions, promoting the advancement of technology and protecting the investor.  Patents often are the most important, and sometimes only, asset of a biotech company. Patents and related rights must be obtained in a timely and predictable manner and the ability to enforce those patents is critical.

BIO Bioprospecting Guidelines

Letters, Testimony & Comments

International Patent Issues Highlighted at House Judiciary Committee Hearing: BIO Submits Biotech's Challenges
April 26 2012
  The House Judiciary Committee conducted a hearing on World IP Day on "International Patent Issues: Promoting...
2012 Special 301 Report: Biotech's International IP Issues
February 14 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
China Compulsory License Proposed Provisions Draw Reaction from BIO
December 9 2011
By Electronic Submission To the State Intellectual Property Office, The Biotechnology Industry Organization (BIO) appreciates this...
International IP and Small Businesses: Novavax CEO Testifies on BIO's Behalf
October 27 2011
By electronic submission Saurabh Vishnubhakat Attorney Advisor, Office of Chief Economist United States Patent and Trademark...
BIO Commends Department of Commerce for Promoting Robust Intellectual Property Standards and Policies Abroad
May 13 2011
Dear Secretary Locke: On behalf of the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of...
More Letters, Testimony & Comments →

Press Releases

BIO Urges U.S. Trade Representative to Preserve IP Protection Abroad
February 21 2011
WASHINGTON, D.C. (Monday, February 21, 2011) - The Biotechnology Industry Organization (BIO) stresses the critical...
BIO Commends USTR for Successfully Concluding U.S.-Korea Free Trade Agreement
April 17 2007
WASHINGTON, D.C. (April 16, 2007) -- The following statement was issued today by Biotechnology Industry Organization...